Cargando…
Current perspectives on CHEK2 mutations in breast cancer
Checkpoint kinase 2 (CHEK2) is a serine/threonine kinase which is activated upon DNA damage and is implicated in pathways that govern DNA repair, cell cycle arrest or apoptosis in response to the initial damage. Loss of kinase function has been correlated with different types of cancer, mainly breas...
Autores principales: | Apostolou, Panagiotis, Papasotiriou, Ioannis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439543/ https://www.ncbi.nlm.nih.gov/pubmed/28553140 http://dx.doi.org/10.2147/BCTT.S111394 |
Ejemplares similares
-
Identification of genes involved in breast cancer and breast cancer stem cells
por: Apostolou, Panagiotis, et al.
Publicado: (2015) -
Cancer Comprehensive Analysis in Gastric Carcinoma: Benefits and New Perspectives
por: Pisanidou, Vasiliki, et al.
Publicado: (2021) -
The risk of breast cancer in women with a CHEK2 mutation
por: Cybulski, Cezary, et al.
Publicado: (2012) -
CHEK2 mutations as markers for high risk of breast cancer
por: Cybulski, Cezary, et al.
Publicado: (2012) -
Gene expression profiling as a potential predictor between normal and cancer samples in gastrointestinal carcinoma
por: Apostolou, Panagiotis, et al.
Publicado: (2019)